As of 2026-03-26, the EV/EBITDA ratio of MEDNAX Inc (MD) is 7.83. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MD's latest enterprise value is 1,980.87 mil USD. MD's TTM EBITDA according to its financial statements is 252.91 mil USD. Dividing these 2 quantities gives us the above MD EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.1x - 13.9x | 12.8x |
| Forward P/E multiples | 10.8x - 12.9x | 11.8x |
| Fair Price | 31.81 - 39.62 | 35.58 |
| Upside | 50.1% - 87.0% | 67.9% |
| Date | EV/EBITDA |
| 2026-03-24 | 7.69 |
| 2026-03-23 | 7.64 |
| 2026-03-20 | 7.34 |
| 2026-03-19 | 7.41 |
| 2026-03-18 | 7.39 |
| 2026-03-17 | 7.32 |
| 2026-03-16 | 7.27 |
| 2026-03-13 | 7.30 |
| 2026-03-12 | 7.26 |
| 2026-03-11 | 7.37 |
| 2026-03-10 | 7.36 |
| 2026-03-09 | 7.47 |
| 2026-03-06 | 7.36 |
| 2026-03-05 | 7.21 |
| 2026-03-04 | 7.40 |
| 2026-03-03 | 7.36 |
| 2026-03-02 | 7.30 |
| 2026-02-27 | 7.39 |
| 2026-02-26 | 7.40 |
| 2026-02-25 | 7.41 |
| 2026-02-24 | 7.46 |
| 2026-02-23 | 7.36 |
| 2026-02-20 | 7.05 |
| 2026-02-19 | 7.21 |
| 2026-02-18 | 8.09 |
| 2026-02-17 | 8.00 |
| 2026-02-13 | 7.94 |
| 2026-02-12 | 7.79 |
| 2026-02-11 | 7.92 |
| 2026-02-10 | 7.80 |
| 2026-02-09 | 7.73 |
| 2026-02-06 | 7.73 |
| 2026-02-05 | 7.71 |
| 2026-02-04 | 7.72 |
| 2026-02-03 | 7.74 |
| 2026-02-02 | 7.91 |
| 2026-01-30 | 7.89 |
| 2026-01-29 | 7.77 |
| 2026-01-28 | 7.66 |
| 2026-01-27 | 7.62 |
| 2026-01-26 | 7.88 |
| 2026-01-23 | 7.95 |
| 2026-01-22 | 8.17 |
| 2026-01-21 | 8.12 |
| 2026-01-20 | 8.01 |
| 2026-01-16 | 8.05 |
| 2026-01-15 | 8.32 |
| 2026-01-14 | 8.10 |
| 2026-01-13 | 8.15 |
| 2026-01-12 | 8.31 |